Aurinia Pharmaceuticals Inc. (AUPH) vs AxoGen, Inc. (AXGN)
A side-by-side comparison of Aurinia Pharmaceuticals Inc. and AxoGen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AUPH
Aurinia Pharmaceuticals Inc.
$15.77HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
AXGN
AxoGen, Inc.
$37.23HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — AUPH vs AXGN
growth of $100 · dividends reinvested · last 10yAUPH +288.1% (+14.5%/yr)AXGN +332.8% (+15.8%/yr)AXGN compounded faster over this window
AUPH AXGN
AUPH vs AXGN: by the numbers
- •AUPH is the larger company ($2.03B vs $2.00B market cap).
- •AUPH is profitable (100.84% net margin) while AXGN runs a net loss (-13.36%).
- •AUPH grew revenue faster over the past five years (40.17% vs 13.99% CAGR).
Metrics side by side
Valuation
| Metric | AUPH | AXGN |
|---|---|---|
| P/E ratio | 6.89 | N/A |
| Forward P/E | 16.71 | 84.14 |
| P/S ratio | 6.51 | 7.97 |
| P/B ratio | 3.30 | 7.81 |
| EV / EBITDA | 11.22 | N/A |
| FCF yield | 8.56% | 0.13% |
Profitability
| Metric | AUPH | AXGN |
|---|---|---|
| Gross margin | 90.36% | 74.56% |
| Operating margin | 37.06% | -5.12% |
| Net margin | 100.84% | -13.36% |
| ROE | 51.09% | -13.09% |
| ROIC | 21.77% | -4.68% |
Growth (annualized)
| Metric | AUPH | AXGN |
|---|---|---|
| Revenue CAGR (5Y) | 40.17% | 13.99% |
| Total return CAGR (5Y) | -5.88% | 19.40% |
Frequently asked
- Which has grown faster, AUPH or AXGN?
- Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus AXGN at 13.99%.
- Is AUPH or AXGN more profitable?
- AUPH runs the higher net margin — AUPH at 100.84% versus AXGN at -13.36%.
- How have AUPH and AXGN total returns compared?
- Over the past 10 years, AUPH delivered 14.53% and AXGN delivered 15.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Aurinia Pharmaceuticals P/E ratioAurinia Pharmaceuticals ROEAxoGen ROEAurinia Pharmaceuticals operating marginAxoGen operating marginAurinia Pharmaceuticals revenue growthAxoGen revenue growthAurinia Pharmaceuticals free cash flowAxoGen free cash flow
Aurinia Pharmaceuticals & AxoGen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.